BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 38499728)

  • 1. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma.
    Asemota J; Saleh M; Igbinovia O; Burns D
    Cureus; 2020 Jul; 12(7):e9191. PubMed ID: 32818122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.
    Wong CR; Nguyen MH; Lim JK
    World J Gastroenterol; 2016 Oct; 22(37):8294-8303. PubMed ID: 27729736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality.
    Burton A; Wilburn J; Driver RJ; Wallace D; McPhail S; Cross TJS; Rowe IA; Marshall A
    Br J Cancer; 2024 Jun; 130(10):1697-1708. PubMed ID: 38499728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017.
    Zalin-Miller A; Jose S; Knott C; Paley L; Tataru D; Morement H; Toledano MB; Khan SA
    World J Gastroenterol; 2023 Jun; 29(24):3825-3842. PubMed ID: 37426314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer diagnoses after emergency GP referral or A&E attendance in England: determinants and time trends in Routes to Diagnosis data, 2006-2015.
    Herbert A; Abel GA; Winters S; McPhail S; Elliss-Brookes L; Lyratzopoulos G
    Br J Gen Pract; 2019 Oct; 69(687):e724-e730. PubMed ID: 31455644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma.
    Rich NE; Hester C; Odewole M; Murphy CC; Parikh ND; Marrero JA; Yopp AC; Singal AG
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):551-559.e1. PubMed ID: 29859983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare.
    Zhang X; El-Serag HB; Thrift AP
    Cancer Causes Control; 2021 Apr; 32(4):317-325. PubMed ID: 33394207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation.
    Burton A; Tataru D; Driver RJ; Bird TG; Huws D; Wallace D; Cross TJS; Rowe IA; Alexander G; Marshall A;
    JHEP Rep; 2021 Apr; 3(2):100232. PubMed ID: 33748727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
    Huang DQ; El-Serag HB; Loomba R
    Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):223-238. PubMed ID: 33349658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
    Plaz Torres MC; Bodini G; Furnari M; Marabotto E; Zentilin P; Strazzabosco M; Giannini EG
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population trends in emergency cancer diagnoses: The role of changing patient case-mix.
    Herbert A; Winters S; McPhail S; Elliss-Brookes L; Lyratzopoulos G; Abel GA
    Cancer Epidemiol; 2019 Dec; 63():101574. PubMed ID: 31655434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
    Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
    Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study.
    Driver RJ; Balachandrakumar V; Burton A; Shearer J; Downing A; Cross T; Morris E; Rowe IA
    BMJ Open; 2019 Jul; 9(7):e028571. PubMed ID: 31292182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data Resource Profile: National Cancer Registration Dataset in England.
    Henson KE; Elliss-Brookes L; Coupland VH; Payne E; Vernon S; Rous B; Rashbass J
    Int J Epidemiol; 2020 Feb; 49(1):16-16h. PubMed ID: 31120104
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.